Showing results (241-250 of 281) with videos related to
Sort By:
Pageof 29
Pediatric Blood & Cancer|April 22, 2011
Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumorsLisa M McGregor, Clinton F Stewart, Kristine R Crews, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
CNS involvement in children with newly diagnosed non-Hodgkin's lymphomaJ T Sandlund, S B Murphy, V M Santana, et al.British Journal of Pharmacology|February 26, 2008
Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in miceM H Mooney, S Fogarty, C Stevenson, et al.European Journal of Cancer (Oxford, England : 1990)|April 24, 2020
Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumoursSara M Federico, Kenneth J Caldwell, Mary B McCarville, et al.Investigational New Drugs|July 29, 2011
A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastomaWayne L Furman, Lisa M McGregor, M Beth McCarville, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2009
Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signalingHafiz Mohmmad Abdul, Michelle A Sama, Jennifer L Furman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report, Maryam Fouladi, Wayne L Furman, et al.Pediatric Blood & Cancer|October 2, 2018
Managing local-regional failure in children with high-risk neuroblastoma: A single institution experienceAustin P Dove, Bogdan-Alexandru Manole, Daniel V Wakefield, et al.Cancer|January 11, 2020
Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime CohortCarmen L Wilson, Tara M Brinkman, Cathleen Cook, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.Pageof 29